Daniel Stout, MD
Gastroenterology · Carmel, INNPI 1336199603
Payments from drug & device makers
Across 30 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braintree Laboratories, Inc.$201
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$199
- Takeda Pharmaceuticals U.S.A., Inc.$47
- AbbVie$46
- Ironwood Pharmaceuticals, Inc$27
- Ferring Pharmaceuticals Inc.$17
- plus $15 from 1 others
What the payments were for
- Food & beverage$38970%
- Gifts$16430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braintree Laboratories, Inc. | 4 | $201 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| AbbVie(2 entities) | 3 | $46 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $15 |
How this compares
$553 in reported general payments places this provider in the 20th percentile of 323 gastroenterology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SimponiGolimumab | 15 | $122,215 |
| Dexlansoprazole DrDexlansoprazole | 46 | $16,135 |
| Mesalamine | 21 | $15,661 |
| Mesalamine ErMesalamine | 12 | $3,002 |
| Omeprazole | 142 | $2,326 |
| Pantoprazole Sodium | 92 | $1,859 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 65 | $962 |
| Lansoprazole | 21 | $595 |
| Rabeprazole Sodium | 19 | $550 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 18 | $300 |
| Esomeprazole Magnesium | 16 | $295 |
| Sucralfate | 11 | $238 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Carmel
- Robert SiwiecCarmel$20K
- Monika FischerIndianapolis$2.8M
- Douglas RexIndianapolis$2.3M
- Pankaj PatelSouth Bend$2.3M
- David PoundIndianapolis$1.4M
- Naga ChalasaniIndianapolis$1.1M
- Sashidhar SagiWestfield$1.1M
- Jonathan ObertNew Albany$758K
- David DresnerNew Albany$544K
- Marwan GhabrilIndianapolis$464K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.